FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080821421> ?p ?o ?g. }

• W3080821421 endingPage "43" @default.
• W3080821421 startingPage "38" @default.
• W3080821421 abstract "Objective Vaginal bromocriptine significantly reduces heavy menstrual bleeding and pain in women with diffuse adenomyosis. The aim of this pilot study was to evaluate whether imaging findings of adenomyosis, as assessed by transvaginal ultrasound (TVU) and magnetic resonance imaging (MRI) reflect changes induced by the bromocriptine treatment. Study design Eighteen women, aged 35–50, with heavy menstrual bleeding reporting Pictorial Blood Loss Assessment Chart (PBLAC) scores >100 and diffuse adenomyosis according to both MRI and TVU were included. The subjects underwent treatment with vaginal bromocriptine for 6 months. MRI and TVU were performed at baseline and after 6 months of medication. Results Mean age of the participants was 44.8 years, 77.8 % reported PBLAC scores > 250 and 66.7 % reported moderate to severe pain during menstruation at baseline. As compared to baseline, TVU revealed a thinner maximal Junctional Zone (JZmax) (8.5 mm [5.2−14] vs 7.9 mm [5−11.2], p = 0.02) at 6 months. Asymmetric wall thickening was seen in 13 (72 %) at baseline, and in 6 (33 %) women at 6 months, p = 0.02. No significant changes were seen in irregular endometrial-myometrial border, presence of fan-shaped shadowing, cystic changes, striations, hyperechogenic islands or lesion extension. MRI showed no significant difference in JZmax (16.0 mm[12.1−27.7] vs 15.5 mm [9.5–25.8], p = 0.81), JZdifference (9.5 mm[4.8−21.6] vs 8.4[3.8−19.5], p = 1) or Ratio JZ/myometrium (0.6 [0.5−0.8] vs. 0.6[0.4−0.8], p = 0.9) at baseline vs 6 month. Cystic lesions in the JZ were found in 9 women (50 %) before, and in 5 women (28 %) at 6 months, p = 0.13. Conclusion TVU showed a significant decrease in JZ max and a reduced number of women with asymmetric myometrial wall thickness. The changes seen in this small pilot study may indicate that vaginal bromocriptine have an impact on adenomyosis that is reflected in radiological appearance." @default.
• W3080821421 created "2020-09-01" @default.
• W3080821421 creator A5005951877 @default.
• W3080821421 creator A5011341219 @default.
• W3080821421 creator A5021933390 @default.
• W3080821421 creator A5070441857 @default.
• W3080821421 creator A5075006014 @default.
• W3080821421 date "2020-11-01" @default.
• W3080821421 modified "2023-10-18" @default.
• W3080821421 title "Vaginal bromocriptine for treatment of adenomyosis: Impact on magnetic resonance imaging and transvaginal ultrasound" @default.
• W3080821421 cites W1587113429 @default.
• W3080821421 cites W1813963939 @default.
• W3080821421 cites W1966951938 @default.
• W3080821421 cites W1967036278 @default.
• W3080821421 cites W1993062940 @default.
• W3080821421 cites W2014463766 @default.
• W3080821421 cites W2016594241 @default.
• W3080821421 cites W2023164644 @default.
• W3080821421 cites W2030038376 @default.
• W3080821421 cites W2035655054 @default.
• W3080821421 cites W2042374015 @default.
• W3080821421 cites W2060544491 @default.
• W3080821421 cites W2071457523 @default.
• W3080821421 cites W2074501002 @default.
• W3080821421 cites W2127396266 @default.
• W3080821421 cites W2154062513 @default.
• W3080821421 cites W2157666779 @default.
• W3080821421 cites W2276751778 @default.
• W3080821421 cites W2413061889 @default.
• W3080821421 cites W2415396582 @default.
• W3080821421 cites W2499161072 @default.
• W3080821421 cites W2563117695 @default.
• W3080821421 cites W2790158216 @default.
• W3080821421 cites W2942413717 @default.
• W3080821421 doi "https://doi.org/10.1016/j.ejogrb.2020.08.040" @default.
• W3080821421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32920421" @default.
• W3080821421 hasPublicationYear "2020" @default.
• W3080821421 type Work @default.
• W3080821421 sameAs 3080821421 @default.
• W3080821421 citedByCount "9" @default.
• W3080821421 countsByYear W30808214212021 @default.
• W3080821421 countsByYear W30808214212022 @default.
• W3080821421 countsByYear W30808214212023 @default.
• W3080821421 crossrefType "journal-article" @default.
• W3080821421 hasAuthorship W3080821421A5005951877 @default.
• W3080821421 hasAuthorship W3080821421A5011341219 @default.
• W3080821421 hasAuthorship W3080821421A5021933390 @default.
• W3080821421 hasAuthorship W3080821421A5070441857 @default.
• W3080821421 hasAuthorship W3080821421A5075006014 @default.
• W3080821421 hasConcept C126322002 @default.
• W3080821421 hasConcept C126838900 @default.
• W3080821421 hasConcept C143409427 @default.
• W3080821421 hasConcept C2776856834 @default.
• W3080821421 hasConcept C2778164554 @default.
• W3080821421 hasConcept C2779064019 @default.
• W3080821421 hasConcept C2779066055 @default.
• W3080821421 hasConcept C2779166600 @default.
• W3080821421 hasConcept C2779522080 @default.
• W3080821421 hasConcept C2779771394 @default.
• W3080821421 hasConcept C2780136519 @default.
• W3080821421 hasConcept C29456083 @default.
• W3080821421 hasConcept C71315377 @default.
• W3080821421 hasConcept C71924100 @default.
• W3080821421 hasConceptScore W3080821421C126322002 @default.
• W3080821421 hasConceptScore W3080821421C126838900 @default.
• W3080821421 hasConceptScore W3080821421C143409427 @default.
• W3080821421 hasConceptScore W3080821421C2776856834 @default.
• W3080821421 hasConceptScore W3080821421C2778164554 @default.
• W3080821421 hasConceptScore W3080821421C2779064019 @default.
• W3080821421 hasConceptScore W3080821421C2779066055 @default.
• W3080821421 hasConceptScore W3080821421C2779166600 @default.
• W3080821421 hasConceptScore W3080821421C2779522080 @default.
• W3080821421 hasConceptScore W3080821421C2779771394 @default.
• W3080821421 hasConceptScore W3080821421C2780136519 @default.
• W3080821421 hasConceptScore W3080821421C29456083 @default.
• W3080821421 hasConceptScore W3080821421C71315377 @default.
• W3080821421 hasConceptScore W3080821421C71924100 @default.
• W3080821421 hasLocation W30808214211 @default.
• W3080821421 hasOpenAccess W3080821421 @default.
• W3080821421 hasPrimaryLocation W30808214211 @default.
• W3080821421 hasRelatedWork W2087075949 @default.
• W3080821421 hasRelatedWork W2103586040 @default.
• W3080821421 hasRelatedWork W2107246442 @default.
• W3080821421 hasRelatedWork W2145153412 @default.
• W3080821421 hasRelatedWork W2426804032 @default.
• W3080821421 hasRelatedWork W2538245960 @default.
• W3080821421 hasRelatedWork W2952630677 @default.
• W3080821421 hasRelatedWork W3000933657 @default.
• W3080821421 hasRelatedWork W3025834139 @default.
• W3080821421 hasRelatedWork W3110269756 @default.
• W3080821421 hasVolume "254" @default.
• W3080821421 isParatext "false" @default.
• W3080821421 isRetracted "false" @default.
• W3080821421 magId "3080821421" @default.
• W3080821421 workType "article" @default.